Evidence map›Paper›PMID 35839085›Full record

ArticleBlood advances2022

Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis.

Karla Cavazos, Sheila Eswaran, Cathleen Maidlow, Fatma Keklik Karadag, Ramazan Idilman, Ilkay Idilman, Ira Miller, Jamile Shammo, Nancy Reau, Celalettin Ustun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Karla CavazosDivision of Hematology, Oncology, and Cellular Therapy, Department of Medicine, Rush University Medical Center, Chicago, IL.
Sheila EswaranDivision of Gastroenterology, Hepatology, and Nutrition, Rush University Medical Center, Chicago, IL.
Cathleen MaidlowDivision of Hematology, Oncology, and Cellular Therapy, Department of Medicine, Rush University Medical Center, Chicago, IL.
Fatma Keklik KaradagDivision of Hematology, Department of Medicine, Ege University, Izmir, Turkey.ORCID 0000-0001-6078-5944
Ramazan IdilmanDivision of Gastroenterology, Department of Medicine, Ankara University, Ankara, Turkey.ORCID 0000-0001-8840-5472
Ilkay IdilmanDepartment of Radiology, Hacettepe University, Ankara, Turkey.ORCID 0000-0002-1913-2404
Ira MillerDepartment of Pathology, Rush University Medical Center, Chicago, IL.
Jamile ShammoDivision of Hematology, Oncology, and Cellular Therapy, Department of Medicine, Rush University Medical Center, Chicago, IL.
Nancy ReauDivision of Gastroenterology, Hepatology, and Nutrition, Rush University Medical Center, Chicago, IL.
Celalettin UstunDivision of Hematology, Oncology, and Cellular Therapy, Department of Medicine, Rush University Medical Center, Chicago, IL.ORCID 0000-0001-6896-6213

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mastocytosis, SystemicAvapritinibHumansLiver CirrhosisPyrazolesPyrrolesAvapritinibPyrazolesPyrroles

Identifiers

PMID35839085
PMCPMC9647789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.